XMax raises $35.96M via registered direct offering of 8.5M shares at $4.23/share

XMax Inc.

8,500,000 shares sold at $4.23 per share, aggregate gross proceeds of $35,955,000.
Per share purchase price equals ~70% of prior trading day's closing price on Nasdaq.
Offering executed under effective shelf registration statement (File No. 333-274970) declared effective Oct 23, 2023.
Net proceeds after offering expenses not specified; closing subject to customary conditions.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

XMax Inc. entered into Securities Purchase Agreement with certain purchasers identified on the signature pages thereto valued at aggregate gross proceeds to the Company of $35,955,000 (effective 2026-03-09).

Action: entry
Agreement: equity purchase
Counterparty: certain purchasers identified on the signature pages thereto
Value: aggregate gross proceeds to the Company of $35,955,000
Effective: 2026-03-09

Exact text from the filing

On March 9, 2026, XMax Inc. (the “Company”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with certain purchasers identified on the signature pages thereto (the “ Purchasers ”), pursuant to which the Company will sell to the Purchasers in a registered direct offering, an aggregate of 8,500,000 shares (the “ Shares ”) of its common stock, par value $0.001 per share (“ Common Stock ”) at a purchase price of $4.23 per share, for aggregate gross proceeds to the Company of $35,955,000, before deducting offering expenses payable by the Company.

View on SEC.gov

272 material agreements filed in the last 30 days. Browse all material agreements →

XMax Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-009569

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.